A novel optical fibre sensing system based on a hybrid long period grating (LPG) and Bragg grating (FBG) configuration is proposed and demonstrated experimentally. The hybrid configuration, which uses the difference in temperature and refractive index (RI) different response of a Bragg grating and a long period grating, makes it possible to discriminate simultaneously the temperature and the refractive index of different aqueous solutions. RI (1.33 RIU–1.40 RIU) and temperature (21°C–28°C) working ranges have been experimentally determined. Experimental results show that the maximum accuracy in the refractive index measurement (0.004 RIU) with temperature compensation has been achieved within the working ranges.

No abstract

The present paper describes a compact point of care (POC) optical device for therapeutic drug monitoring (TDM). The core of the device is a disposable plastic chip where an immunoassay for the determination of immunosuppressants takes place. The chip is designed in order to have ten parallel microchannels allowing the simultaneous detection of more than one analyte with replicate measurements. The device is equipped with a microfluidic system, which provides sample mixing with the necessary chemicals and pumping samples, reagents and buffers into the measurement chip, and with integrated thin film amorphous silicon photodiodes for the fluorescence detection. Submicrometric fluorescent magnetic particles are used as support in the immunoassay in order to improve the efficiency of the assay. In particular, the magnetic feature is used to concentrate the antibody onto the sensing layer leading to a much faster implementation of the assay, while the fluorescent feature is used to increase the optical signal leading to a larger optical dynamic change and consequently a better sensitivity and a lower limit of detection. The design and development of the whole integrated optical device are here illustrated. In addition, detection of mycophenolic acid and cyclosporine A in spiked solutions and in microdialysate samples from patient blood with the implemented device are reported. Graphical abstract